Post procedural pulmonary embolism is a serious complication that can occur after surgical procedures, particularly those involving the legs, pelvis, or abdomen. This condition happens when a blood clot travels from another part of the body to the lungs, blocking blood flow and potentially causing severe health consequences. Understanding how this condition is diagnosed can be lifesaving, as early detection and treatment are critical for recovery.

Introduction: Who Should Undergo Diagnostics

People who have recently undergone surgery need to be especially aware of the signs that might indicate a pulmonary embolism. If you experience sudden shortness of breath, chest pain that worsens when you breathe deeply, rapid breathing, or a cough that may produce bloody mucus, you should seek medical attention immediately. These symptoms can appear within hours, days, or even weeks after a surgical procedure.^[1]

The risk of developing a pulmonary embolism after surgery is highest during the first five weeks following the procedure. Research has shown that the risk remains particularly elevated between one and six weeks after surgery, though it can persist for up to 12 weeks for certain types of operations. After about 18 weeks, the risk returns to normal levels.^[2]

You should seek diagnostic testing if you notice any sudden changes in your breathing or chest discomfort after surgery. Some people may experience symptoms that develop gradually over several days or weeks, while others may have symptoms that appear suddenly within minutes. Even if your symptoms seem mild at first, they can worsen quickly, so it’s important not to delay getting medical help.^[5]

Certain factors make some people more likely to need diagnostic testing after surgery. If you have had major surgery on your abdomen, pelvis, or legs, your risk is particularly high. The period of physical inactivity during and after surgery can cause blood to pool in your veins, which increases the chance of clot formation. Other risk factors include advanced age, obesity, a history of blood clots, cancer, and certain inherited blood clotting disorders.^[1]

If you notice swelling, pain, discoloration, or tenderness in your leg or arm after surgery, this could indicate a deep vein thrombosis, which is when a blood clot forms in a deep vein. This is the most common cause of pulmonary embolism. A blood clot in your leg can break free and travel through your bloodstream to your lungs. If you have these symptoms, you should contact your doctor right away for diagnostic testing.^[2]

Classic Diagnostic Methods

Diagnosing a pulmonary embolism can be challenging because the symptoms are similar to those of other conditions, such as heart attacks or other lung problems. For this reason, doctors use multiple approaches to confirm the diagnosis. The diagnostic process typically begins with gathering information about your medical history and symptoms, followed by a physical examination and various tests.^[3]

Medical History and Physical Examination

Your doctor will start by asking detailed questions about your recent surgery, your symptoms, and your medical history. They want to know when your symptoms started, how severe they are, and whether you have any risk factors for blood clots. During the physical exam, the doctor will look for swollen or discolored areas on your arms or legs that might suggest a deep vein thrombosis. They will also listen to your heart and lungs with a stethoscope and check your blood pressure.^[2]

Blood Tests

One of the first tests your doctor may order is a D-dimer blood test. D-dimer is a substance that appears in your bloodstream when a blood clot breaks down. If your D-dimer levels are high, this suggests that you may have a blood clot somewhere in your body. However, this test is not specific to pulmonary embolism, as many other conditions can also cause elevated D-dimer levels. For this reason, doctors use it as an initial screening tool rather than a definitive diagnostic test.^[7]

Blood tests can also measure the amount of oxygen and carbon dioxide in your blood. When a blood clot blocks a blood vessel in your lung, it can lower the oxygen level in your blood. Additionally, doctors may check for elevated levels of certain markers like troponin and brain natriuretic peptide, which can indicate stress on your heart caused by the embolism.^[7]

Chest X-Ray

A chest X-ray is a common imaging test that creates pictures of your heart and lungs. While an X-ray cannot directly diagnose a pulmonary embolism and may even appear normal when an embolism is present, it is useful for ruling out other conditions that cause similar symptoms, such as pneumonia or a collapsed lung.^[7]

Ultrasound of the Legs

Doctors often perform an ultrasound of your legs to look for deep vein thrombosis. This test, called duplex ultrasonography or compression ultrasonography, uses sound waves to create images of the veins in your thighs, knees, and calves. A technician moves a wand-shaped device over your skin, and the sound waves bounce back to create a moving picture on a computer screen. If this test finds blood clots in your leg veins, it strongly suggests that you may have or be at risk for a pulmonary embolism, even if the clot has not yet reached your lungs.^[7]

CT Pulmonary Angiography

Computed tomography pulmonary angiography, often abbreviated as CTPA or CT scan, is considered the gold standard for diagnosing pulmonary embolism. This test uses X-rays to create detailed cross-sectional images of your chest. During the procedure, a special dye is injected into your vein, which makes your blood vessels visible on the images. The CT scanner can then show whether a blood clot is blocking any of the arteries in your lungs.^[3][8]

The CT scan generates images that allow doctors to see exactly where the clot is located and how large it is. This information helps them determine the severity of your condition and plan the appropriate treatment. Because of its accuracy and availability, CT pulmonary angiography has become the most commonly used test for confirming a pulmonary embolism diagnosis.^[8]

Additional Imaging Tests

In some cases, doctors may use other imaging tests to help diagnose a pulmonary embolism. A ventilation-perfusion scan, also called a V-Q scan, compares air flow and blood flow in your lungs. This test is sometimes used when a CT scan cannot be performed, such as in patients who are allergic to the contrast dye used in CT scans.^[7]

Magnetic resonance imaging, or MRI, is another option that uses magnets and radio waves instead of X-rays to create detailed images of your body. While MRI can detect pulmonary embolisms, it is not commonly used for this purpose because CT scans are faster and more readily available in emergency situations.^[7]

An echocardiogram uses ultrasound to create images of your heart. While this test cannot directly show a blood clot in your lungs, it can reveal signs of strain on your heart caused by a pulmonary embolism. Doctors may order an echocardiogram to assess how well your heart is functioning and to guide treatment decisions.^[7]

Diagnostics for Clinical Trial Qualification

When patients with post procedural pulmonary embolism are being considered for enrollment in clinical trials, specific diagnostic tests and criteria are used to determine their eligibility. Clinical trials test new treatments or procedures, and researchers need to ensure that participants have been accurately diagnosed and meet certain health standards.

The foundation of qualification for clinical trials typically requires confirmation of pulmonary embolism through computed tomographic pulmonary angiography, as this is recognized as the gold standard for diagnosis. Trial protocols may specify the timing of when the embolism occurred relative to the surgical procedure, such as requiring that the diagnosis was made within a certain number of weeks after surgery.^[8]

Clinical trials may also require documentation of the severity of the pulmonary embolism. Researchers might use specific measurements from diagnostic tests to categorize patients. For example, they may assess blood pressure readings, with some trials focusing on patients who have experienced low blood pressure (systolic blood pressure below 90 mm Hg) as a result of their embolism, which indicates a more severe, life-threatening condition.^[13]

Blood test results play an important role in clinical trial qualification. Trials may require specific D-dimer levels or other blood markers to be above or below certain thresholds. Some studies examine patients with elevated troponin or brain natriuretic peptide levels, which indicate heart stress, while others may exclude patients with certain blood abnormalities.^[7]

Researchers conducting clinical trials often need to verify that patients do not have underlying conditions that could interfere with the study results or put participants at additional risk. This means patients may undergo additional diagnostic tests beyond those used for the initial diagnosis. These might include tests to rule out inherited blood clotting disorders, cancer screenings, kidney function tests, and liver function tests.

The documentation of risk factors is also important for clinical trial enrollment. Researchers typically collect detailed information about the surgical procedure that preceded the pulmonary embolism, including the type of surgery, its duration, and any complications. They may also assess other risk factors such as obesity, smoking history, use of hormone medications, and previous blood clots. This information helps researchers understand whether certain treatments work better for specific patient populations.

Imaging studies beyond the initial CT scan may be required for trial qualification. Some protocols require repeat imaging at specific time points to assess how the blood clot is changing over time. Ultrasound examinations of the legs might be performed to check for ongoing deep vein thrombosis. Echocardiograms may be repeated to monitor heart function throughout the trial period.

Clinical trials may also require assessment of a patient’s overall functional status and ability to participate in the study. This might involve tests that measure how well patients can perform daily activities, their breathing capacity through pulmonary function tests, and their exercise tolerance. These assessments help researchers understand the impact of the pulmonary embolism on quality of life and whether new treatments can improve functional outcomes.

The timing and frequency of diagnostic tests during a clinical trial are carefully planned in the study protocol. Patients may need to undergo blood tests, imaging studies, and physical examinations at regular intervals throughout the trial period. This systematic approach helps researchers collect consistent data across all participants and monitor for any adverse effects of the experimental treatment.